Patent · US Active

Fused heterocyclic compound

US10577382B2 · kind B2 · utility

2Cited by
1References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 27, 2017
Grant dateMar 3, 2020
Priority date—
Expiry dateApr 27, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided is a compound represented by the following formula, or a salt thereof:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.